New device could predict who benefits from constipation therapy

NCT ID NCT05807321

First seen Oct 31, 2025 · Last updated Apr 29, 2026 · Updated 29 times

Summary

This study tests a new device called Fecobionics to better understand constipation caused by pelvic floor dyssynergia. Researchers will use the device to measure how the rectum and anus work during defecation in 24 adults. The goal is to see if these measurements can predict how well patients will respond to biofeedback therapy, a common treatment for this condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSSYNERGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • California Medical Innovations Institute

    RECRUITING

    San Diego, California, 92121, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Digestive Health Center- Augusta University

    RECRUITING

    Augusta, Georgia, 30912, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.